Synoptics Health launches ProReveal Test

Singapore: Synoptics Health, a world leader in the development and manufacture of innovative digital imaging systems for scientific applications, has launched ProReveal Test, a rapid in-situ fluorescence-based method of detecting proteins on surgical instruments.

Mr Paul Ellwood, CEO, Synoptics Health, said that, "We are delighted to be introducing our revolutionary new test at the leading show for medical technology innovation. The ProReveal Test uses very sensitive, yet cost-effective fluorescence technology and will tell you exactly where, and how much protein is on your surgical instrument."

"This is a significant quality enhancement from current testing available and there isn't any other affordable fluorescence-based test designed for this application that is commercially available," added Mr Ellwood.